Robuta

https://www.statnews.com/topic/drug-prices/ STAT Drug Prices - The Cost Issues of Prescription Drugs News and analysis on drug prices. Read about the rising cost of prescription drugs, the impact on the healthcare system and efforts to lower costs. stat drugprescription drugspricescostissues https://www.statnews.com/topic/drug-pricing/ STAT Drug Pricing - Exploring High Cost Prescriptions in Depth STAT covers the high cost of prescription drugs, the use of patent law to curb competition and boost profits, and the role of PBMs in high drug prices. stat drugexploring highpricingcostprescriptions https://www.statnews.com/topic/drug-development/ STAT Drug Development - News, Research, Policy and More STAT News covers the latest news, research, and policy on drug development. Read about the challenges and opportunities of bringing new drugs to market. development news researchstat drugpolicy https://www.statnews.com/pharmalot/2026/04/13/revolution-pancreatic-cancer-pill-fda-rejects-replimune-cancer-drug/ Pharmalittle: Pancreas cancer data strong, Replimune drug rejected| STAT Apr 13, 2026 - The FDA rejected — again — an experimental treatment for advanced skin cancer developed by Replimune, which has become a flashpoint. pancreas cancerdrug rejectedpharmalittledatastrong https://www.statnews.com/2025/11/24/alzheimers-disease-johnson-and-johnson-posdinemab/ J&J’s novel Alzheimer’s drug posdinemab fails in key trial | STAT Nov 24, 2025 - The results could cast shadow over other experimental therapies aimed at the protein tau from companies including Biogen, UCB, and Voyager. key trialjnoveldrugfails https://www.statnews.com/pharmalot/2026/03/26/fda-rare-disease-pto-novo-nordisk-340b-abortion-hiv/ Pharmalittle: FDA approves rare disease drug, PTO chief grilled | STAT Mar 26, 2026 - A bipartisan quartet of senators unveiled legislation to cap the monthly cost of insulin at $35 for patients on private insurance. rare disease drugpharmalittle fdaapprovesptochief https://www.statnews.com/2025/11/06/trump-drug-price-deal-burning-questions/ Trump drug price deal: Burning questions after Lilly, Novo agreement | STAT Nov 7, 2025 - Trump weight loss drug announcement raises questions on impact on commercial market, role of Medicare negotiations, potential backlash from MAHA trump drugprice dealburning questionslilly novoagreement https://www.statnews.com/2026/02/17/ocular-therapeutix-axpaxli-wet-amd-treatment-compared-to-eylea-regeneron/ Ocular Therapeutix wet AMD drug Axpaxli tops Eylea in study | STAT Feb 17, 2026 - Ocular now plans to apply for FDA approval, but whether doctors and insurers will favor its new drug is an open question. ocular therapeutixwet amdstudy statdrugtops https://www.statnews.com/pharmalot/2017/10/10/california-bans-drug-coupons/ California bans drug coupons when cheaper alternatives are available | STAT Jul 25, 2023 - The law reflects mounting controversy over the role that coupons play in the debate over rising health care costs and prescription medicines, in particular. california banscheaper alternativesdrugcouponsavailable https://www.statnews.com/2026/03/19/biotech-uses-apple-watch-parkinsons-drug-study-health-tech/ STAT Health Tech: A biotech turns to Apple Watch to study its Parkinson's drug Mar 19, 2026 - In this edition of STAT Health Tech: How Apple Watch is being used in a clinical trial for a Parkinson's drug, and some insights into how physicians are using... stat health techapple watchbiotechturnsstudy https://www.statnews.com/2026/04/01/insilico-medicine-ceo-biotech-drug-development-ai-prognosis/ Insilico Medicine CEO on how best to use AI in drug development | STAT Apr 1, 2026 - In this edition of STAT's AI Prognosis: How to be a 'productive' biotech AI company, with Insilico Medicine CEO Alex Zhavoronkov, and more. insilico medicineuse aidrug developmentceobest https://www.statnews.com/topic/pharma/ STAT Pharma Coverage: Clinical Trials, Drug Development, Pricing News and analysis of the pharmaceutical industry, including coverage of the biggest players in Big Pharma. clinical trials drugstat pharmadevelopment pricingcoverage https://www.statnews.com/topic/pharmaceuticals/ STAT Pharmaceuticals - In-depth Drug Industry Coverage Coverage of the pharmaceutical industry, including drug development, pricing and regulation.See the latest research and developments in drug discovery. drug industrystatpharmaceuticalsdepthcoverage https://www.statnews.com/2025/10/16/readout-loud-podcast-clive-meanwell-metsera-obesity/ Readout LOUD: Clive Meanwell on drug pricing, obesity market | STAT Oct 16, 2025 - Meanwell chatted about the evolving obesity drug market, and the continued need for drugs to treat diseases with large prevalence. readout louddrug pricingobesity marketclivemeanwell https://www.statnews.com/2026/03/19/340b-reform-medicare-drug-price-negotitation-program/ How a 340B successor might arise from the drug price negotiations | STAT Apr 13, 2026 - The closer we get to 2028, the more likely it is that the U.S. may settle for short-term solutions that do not meaningfully reform the health care system. drug price negotiations340bsuccessormightarise https://www.statnews.com/2026/03/24/trump-mfn-drug-pricing-gop-strategy-raise-prices-overseas/ Trump’s drug plan hinges on a strategic bet: Raising prices abroad | STAT Trump health official is telling Republicans MFN drug pricing isn't about lowering U.S. costs. It's about forcing the world to pay more. drug planraising priceshingesstrategicbet https://www.statnews.com/pharmalot/2026/04/22/medicare-obesity-drug-pilot-program-experimental-roche-ms-drug/ Pharmalittle: Medicare drops obesity drug pilot, Roche touts MS data | STAT Apr 22, 2026 - Roche presented the latest data for its experimental multiple sclerosis drug, setting the stage for the company to seek FDA approval. obesity drugpharmalittlemedicaredropspilot https://www.statnews.com/2026/03/30/biotech-news-biogen-lupus-drug-improves-skin-clearance-in-trial/ Biogen lupus drug improves skin clearance in mid-stage study | STAT Mar 30, 2026 - Today's biotech news covers a positive mid-stage study for Biogen lupus drug, Takeda's competitive Phase 3 psoriasis data, and more. mid stagestudy statbiogenlupusdrug https://www.statnews.com/2025/06/17/weight-loss-drug-development-chinese-pharma-pursuit-next-obesity-blockbuster/ Weight loss drug development is booming in China. Here's why | STAT Jun 17, 2025 - STAT’s Obesity Drug Tracker update looks at how China, a country with a low percentage of overweight people, became a hotbed of weight loss drug trials. weight loss drugdevelopmentboomingchinastat https://www.statnews.com/category/biotech/page/2/ STAT Biotech news: Market-moving coverage of drug development Biotech news coverage that goes inside the discoveries that drive the biotechnology industry. Sign up for The Readout, our life sciences newsletter. stat biotechnews marketdrug developmentmovingcoverage https://www.statnews.com/2026/04/27/veradermics-hair-loss-drug-succeeds-late-stage-trial/ Veradermics’ hair loss drug succeeds in late-stage trial | STAT The company is one of the most advanced players in the hair loss field, which has seen a surge of investor enthusiasm. hair loss druglate stagetrial statsucceeds https://www.statnews.com/pharmalot/2026/03/05/gilead-hiv-aids-south-africa-ilcense-lenacapavir/ Gilead, South Africa negotiate license to produce HIV drug locally| STAT Mar 5, 2026 - South Africa has the world’s highest HIV burden with about 8 million HIV-positive people, or 1 in 5 adults, as of last year south africahiv druggileadnegotiatelicense https://www.statnews.com/2026/03/10/ron-johnson-investigating-fda-rare-disease-drug-denials/ GOP Sen. Johnson investigating FDA rare disease drug rejections | STAT Mar 10, 2026 - Sen. Ron Johnson has long been an advocate for giving people with rare diseases speedy access to experimental treatments. rare disease druggop senjohnsoninvestigatingfda https://www.statnews.com/2026/02/05/super-bowl-ads-drug-companies-fda-rules/ Super Bowl ads highlight tension between FDA and drug companies | STAT FDA announced a crackdown on TV pharmaceutical advertising last fall. This week's STATus Report looks at which Super Bowl ads may be pushing the limits. super bowl adsdrug companieshighlighttensionfda https://www.statnews.com/category/pharma/ STAT Pharma: The science and business of new drug development STAT coverage and analysis of top pharmaceutical companies, from clinical trials to FDA approvals, from startups to Big Pharma mergers and acquisitions. stat pharmanew drugsciencebusinessdevelopment https://www.statnews.com/pharmalot/2026/04/23/telehealth-visits-pharma-withholding-new-meds-in-europe/ Pharmalittle: Drug firms offer telehealth coupons; GLP-1 pill for kids? | STAT Apr 23, 2026 - HHS Secretary Robert F. Kennedy Jr. told ​a Senate hearing he had nothing to do with an FDA ‌decision to not approve Replimune's cancer drug glp 1 pillpharmalittledrugfirmsoffer https://www.statnews.com/pharmalot/2026/04/03/trump-pharma-tariffs-uk-trade-deal/ Pharmalittle: Drug tariffs imposed, U.K. reaches pharma trade deal | STAT Apr 3, 2026 - A pharmaceutical trade deal grants ‌U.K. tariff-free access for its drugs in the U.S. in return for paying higher prices for new U.S. meds. drug tariffstrade dealpharmalittleimposedk https://www.statnews.com/2026/02/27/trump-drug-prices-pharma-mfn-deals-3-year-terms/ Trump's MFN drug pricing deals run 3 years, some companies say | STAT Feb 27, 2026 - Details of 'most-favored nation' deals with drugmakers have not been disclosed, but SEC filings reveal some expire after three years. mfn drug pricingrun 3companies saytrumpdeals https://www.statnews.com/2026/04/23/gop-drug-policy-trump-psychedelics-marijuana/ GOP drug policy shifting as Trump boosts psychedelics, marijuana | STAT Apr 23, 2026 - The Trump administration, in a stark departure from the drug policygopshiftingtrumpboosts https://www.statnews.com/category/pharma/page/2/ STAT Pharma: The science and business of new drug development STAT coverage and analysis of top pharmaceutical companies, from clinical trials to FDA approvals, from startups to Big Pharma mergers and acquisitions. stat pharmanew drugsciencebusinessdevelopment https://www.statnews.com/2026/03/05/tylenol-use-drop-after-trump-link-acetamenophen-autism/ Tylenol orders for pregnant people dropped after Trump linked the drug to autism | STAT Mar 6, 2026 - In the weeks following health officials linking Tylenol to autism, the drug's use in pregnant women visiting ERs dropped, new study shows pregnant peopletrump linkedtylenolordersdropped https://www.statnews.com/2026/03/19/chris-klomp-hhs-medicare-discusses-mfn-drug-pricing-trumprx/ Chris Klomp discusses Trump's MFN drug pricing goals, TrumpRx | STAT Mar 19, 2026 - TrumpRx was never designed for the vast majority of Americans whose medications are covered by health insurance, Klomp said at STAT's Breakthrough Summit. mfn drug pricingtrumprx statchrisklompdiscusses https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/ Weight loss drugs on the horizon: STAT's Obesity Drug Tracker Jun 17, 2025 - Our database tracks the new weight loss drugs that could hit the market, novel mechanisms, and which companies are in the hunt. weight loss drugshorizonstatobesitytracker https://www.statnews.com/2025/12/04/fda-tracy-beth-hoeg-psychedelics-future-readout-loud-podcast/ Readout LOUD podcast: A new FDA top drug regulator | STAT Dec 4, 2025 - The turmoil at the FDA continues: Richard Pazdur has announced his retirement, and he's being replaced by Covid contrarian Tracy Beth Høeg. readout loud podcastnew fdatop drugregulatorstat https://www.statnews.com/topic/clinical-trials/ STAT Clinical Trials: Latest News on Research and Drug Development Read STAT's in-depth coverage of clinical trial research, including the latest news and research, and ethical and regulatory issues in biotech and pharma. clinical trialslatest newsdrug developmentstatresearch https://www.statnews.com/feature/medicine-hunters/part-1/ Before signing up for drug trial, she wants to know: Can I afford it? | STAT Jul 31, 2023 - A cancer patient's question serves as a wake-up call for the drug industry: Will she be able to afford the treatment she’d help usher into the world? drug trialsigningwantsknowafford https://www.statnews.com/2026/04/23/trump-drug-price-deal-regeneron-mfn-negotiations/ Trump closes first round of drug price negotiations with Regeneron deal | STAT Apr 23, 2026 - Trump finalizes drug price deal with Regeneron, the 17th pharma company to reach an agreement to lower some prices, and avoid punitive tariffs. drug price negotiationscloses firstdeal stattrumpround https://www.statnews.com/2026/03/23/zumilokibart-apogee-eczema-clinical-trials-results/ Apogee eczema drug zumilokibart appears to offer long-lasting relief | STAT Mar 23, 2026 - Apogee's long-lasting eczema treatment is the latest in the race to develop next-gen medicines for atopic dermatitis. long lastingapogeeeczemadrugappears https://www.statnews.com/2026/03/19/eli-lilly-retatrutide-in-vivo-cart-readout-newsletter/ Readout Newsletter: Eli Lilly’s 'triple-G' drug delivers striking results | STAT Mar 19, 2026 - Today's biotech news roundup includes new Phase 3 results on Lilly's experimental obesity drug retatrutide. readout newslettertriple gresults statelidrug https://www.statnews.com/2025/12/09/ash-jandj-multiple-myeloma-and-cdc-sickle-cell-data/ J&J's two-drug combo blocked tumors in advanced multiple myeloma | STAT two drugmultiple myelomajcomboblocked https://www.statnews.com/2026/04/16/travere-therapeutics-kidney-disease-fda-approval/ Travere drug doesn’t improve kidney function. The FDA still approved it | STAT The agency has taken heat for not showing enough regulatory flexibility. In the case of Filspari, it showed too much. kidney functiontraveredrugimprovefda https://www.statnews.com/2025/07/17/senators-investigate-pharma-telehealth-payments-for-possible-kickbacks/ Drug company payouts to telehealth providers revealed by senators | STAT Jul 17, 2025 - Four senators are investigating partnerships between direct-to-consumer telehealth firms and pharma companies for possible violations of kickback laws. drug companypayoutstelehealthprovidersrevealed https://www.statnews.com/2026/03/18/fda-nih-reduce-animal-testing-drug-development/ FDA and NIH push to reduce animal testing in drug development | STAT Mar 18, 2026 - FDA released guidance to help drug companies assess their products without animals. NIH will offer grants to find alternatives. reduce animal testingdrug developmentfdanihpush https://reports.statnews.com/collections/all-reports/products/failed-trial-successful-drug Failed trial, successful drug: How a negative readout can lead to FDA | STAT Reports In this STAT Report author Frank David, M.D., Ph.D., explores the question, how can you tell if there’s still hope a drug will be approved when a pivotal trial... successful drugfda statfailedtrialnegative https://reports.statnews.com/collections/all-reports/products/speed-and-safety-fdas-drug-approval A guide to the FDA's drug approval pathways and processes | STAT Reports Our latest report unpacks the differences between the different ways the FDA approves drugs, like accelerated approvals, fast-track designations, and emergency... drug approvalstat reportsguidefdapathways https://www.statnews.com/2024/09/05/obesity-drug-tracker-amylin-weight-loss-drugs-novo-nordisk-eli-lilly-zealand-pharma/ Obesity drug tracker: Can amylin drugs upend Wegovy, Zepbound? | STAT Sep 5, 2024 - Novo Nordisk and Eli Lilly, makers of blockbuster GLP-1 drugs, test amylin hormone receptor treatments in pursuit of fewer side effects. obesity drugwegovy zepboundtrackeramylindrugs